Home › Funds › Monashee Investment Management LLC › SLDB

Monashee Investment Management LLC position in SLDB

SOLID BIOSCIENCES INC · Health Care

Monashee Investment Management LLC reported holding 410,000 shares of SLDB (SOLID BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 10.50% of its reported portfolio and ranking #5 among its reported holdings. Monashee Investment Management LLC has disclosed SLDB holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)410.00K sh
Reported value held$2.96M
Portfolio Weight10.50%
First reportedQ1 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Monashee Investment Management LLC's SLDB position evolved

Monashee Investment Management LLC first disclosed a stake in SLDB in Q1 2024 at 620,000 shares (US$8.3M). The position peaked in Q2 2025 at 2,165,000 shares, worth US$10.5M. Across 10 filings, Monashee Investment Management LLC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 410,000 shares valued at US$3.0M — a reduction of -90,000 shares quarter over quarter.. Notable position changes include a 249% increase in Q1 2025 (shares rose 32% over the following quarter), a 29% increase in Q2 2025 (shares rose 27% over the following quarter), a 65% trim in Q2 2026 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 620.00K $8.26M New
Q2 2024 450.00K $2.55M Reduce
Q3 2024 485.00K $3.38M Add
Q4 2024 480.00K $1.92M Reduce
Q1 2025 1.67M $6.19M Add
Q2 2025 2.17M $10.54M Add
Q4 2025 1.35M $7.61M New
Q1 2026 1.42M $10.23M Add
Q2 2026 500.00K $5.00M Reduce
Q3 2026 410.00K $2.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLDB and 13F data

SLDB (SOLID BIOSCIENCES INC) is a Health Care company. 45 other funds we track also report a position in SLDB — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$120.2M), PERCEPTIVE ADVISORS LLC (US$118.9M), Bain Capital Life Sciences Investors, LLC (US$98.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLDB

All SLDB fund holders →

FAQ

How long has Monashee Investment Management LLC held SLDB?

Monashee Investment Management LLC has disclosed SLDB holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

What is Monashee Investment Management LLC's current position in SLDB?

As of Q3 2026, Monashee Investment Management LLC holds 410.00K shares of SLDB (SOLID BIOSCIENCES INC), valued at $2.96M, representing 10.50% of its reported portfolio and ranking #5.

Has Monashee Investment Management LLC been buying or selling SLDB?

In the latest 13F filing (Q3 2026), Monashee Investment Management LLC reduced its position in SLDB. The position peaked in Q2 2025 at 2.17M shares.

Which other funds hold SLDB?

Other major institutional holders of SLDB include RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.